Intercostal Cryoanalgesia for Post-Operative Pain After Double Lung Transplant
This study is exploring a new approach to manage pain after a double lung transplant. Doctors will use a cold-therapy probe, called the Atricure CryoSPHERE MAX Probe, during surgery to gently freeze nerves near the incision. This aims to reduce pain and potentially lower the need for strong pain medications (opioids) after your surgery. You may be eligible if you are an adult (18 years or older) undergoing a double lung transplant. The main goal is to see if this treatment can reduce the total amount of opioids you need in the first year after surgery. The study's current status is unclear, and it plans to enroll 148 participants.
- Study design
- This is an interventional study planning to enroll 148 participants. It compares patients receiving the Atricure CryoSPHERE MAX Probe to those receiving usual care.
- What's involved
- Patients will receive the Atricure CryoSPHERE MAX Probe treatment during their double lung transplant procedure. They will be followed for one year after their transplant.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for one year after their transplant procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
At a glance
Conditions
Where it's being run
3 sites across 2 statesStudy leadership
- Abbas Ardehali, MD · PRINCIPAL_INVESTIGATOR · University of California, Los Angeles
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Total opioid use (oral morphine equivalents)1 year
Total opioid use (oral morphine equivalents)